FPRX

Five Prime Therapeutics, Inc.

FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

172 hedge funds and large institutions have $1.26B invested in Five Prime Therapeutics, Inc. in 2016 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 57 increasing their positions, 73 reducing their positions, and 19 closing their positions.

2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1 2016 Q4 2016 Q3 2016 Q2 2016 Q1 2015 Q4 2015 Q3 2015 Q2 2015 Q1 2014 Q4 2014 Q3 2014 Q2 2014 Q1 2013 Q4 2013 Q3

Holders

172

Holders Change

-4

Holders Change %

-2.27%

% of All Funds

4.31%

Holding in Top 10

Holding in Top 10 Change

-1

Holding in Top 10 Change %

-33.33%

% of All Funds

0.05%

New

Increased

Reduced

Closed

Calls

$1.04M

Puts

$1K

Net Calls

+$1.04M

Net Calls Change

+$7.51M

Top Buyers

1	1 Vanguard Group Malvern, Pennsylvania	$109M
2	2 Mackenzie Financial Toronto Ontario, Ontario, Canada	$12.8M
3	3 Norges Bank Oslo, Norway	$7.08M
4	BFA 4 BlackRock Fund Advisors San Francisco, California	$61M
5	5 UBS AM Chicago, Illinois	$7.83M

Top Sellers

1	1 Goldman Sachs New York	$4.5M
2	2 Arrowstreet Capital Boston, Massachusetts	$0
3	BIM 3 Bogle Investment Management Newton Lower Falls, Massachusetts	$0
4	4 Adage Capital Partners Boston, Massachusetts	$95.2M
5	EAM 5 Eventide Asset Management Boston, Massachusetts	$40.6M

#	Name	Market Value	Shares	Shares Change	Shares Change %
26	26 Capital Fund Management (CFM) Paris, France	$8.37M	166,945	+13,265	+9%
27	RSCM 27 Rock Springs Capital Management Baltimore, Maryland	$8.22M	164,000	-2,250	-1%
28	PA 28 Perceptive Advisors New York	$8.18M	163,255	-3,254	-2%
29	29 UBS AM Chicago, Illinois	$7.83M	156,301	+129,404	+481%
30	30 Wells Fargo San Francisco, California	$7.8M	155,565	-1,980	-1%
31	31 JPMorgan Chase & Co New York	$7.79M	155,500	+25,725	+20%
32	32 Norges Bank Oslo, Norway	$7.08M	141,283	+141,283	New
33	DM 33 Deerfield Management New York	$6.92M	138,000	-173,000	-56%
34	MCM 34 Matarin Capital Management New York	$6.45M	128,661	+11,358	+10%
35	35 AQR Capital Management Greenwich, Connecticut	$6.42M	128,095	-54,813	-30%
36	HSA 36 Hussman Strategic Advisors Ellicott City, Maryland	$5.76M	115,000	-10,000	-8%
37	37 Lord, Abbett & Co Jersey City, New Jersey	$5.73M	114,397	+1,335	+1%
38	BIM 38 BlackRock Investment Management Wilmington, Delaware	$5.45M	108,726	-733	-0.7%
39	39 Morgan Stanley New York	$5.41M	107,934	+75,424	+232%
40	40 Citigroup New York	$5.15M	102,668	+86,633	+540%
41	HA 41 Hays Advisory Franklin, Tennessee	$4.8M	95,710	-27,438	-22%
42	42 Deutsche Bank Frankfurt Am Main Ge, Germany	$4.64M	92,634	-6,131	-6%
43	43 Goldman Sachs New York	$4.5M	89,769	-564,583	-86%
44	44 AllianceBernstein Nashville, Tennessee	$4.49M	89,550	-18,200	-17%
45	AIC 45 AWM Investment Company New York	$4.01M	80,000	–	–
46	CS 46 Credit Suisse Zurich, Switzerland	$3.81M	76,053	-643	-0.8%
47	GCP 47 GSA Capital Partners London, United Kingdom	$3.62M	72,279	+1,279	+2%
48	OAM 48 Oxford Asset Management Oxford, United Kingdom	$3.45M	68,826	+15,678	+29%
49	VIA 49 Vident Investment Advisory Alpharetta, Georgia	$3.28M	65,541	-9	-0%
50	50 Prudential Financial Newark, New Jersey	$3.25M	64,786	+15,800	+32%

Five Prime Therapeutics, Inc. FPRX

Top Buyers

Top Sellers

Five Prime Therapeutics, Inc.

FPRX